Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria
Ricardo Amorim, Carina C. Magalhães, Fernanda Borges, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 595-595
Open Access | Times Cited: 17

Showing 17 citing articles:

Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
Youwei Zheng, Shiting Wang, Jialiang Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52
Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
Changrui Long, Xiaoyan Zhou, Fan Xia, et al.
Biology (2024) Vol. 13, Iss. 4, pp. 243-243
Open Access | Times Cited: 8
The emerging significance of mitochondrial targeted strategies in NAFLD treatment
Tao Zhang, Yingli Nie, Jiliang Wang
Life Sciences (2023) Vol. 329, pp. 121943-121943
Closed Access | Times Cited: 11
Chemical Characterization and Differential Lipid-Modulating Effects of Selected Plant Extracts from Côa Valley (Portugal) in a Cell Model for Liver Steatosis
Ricardo Amorim, Mário Pedro Marques, Catarina Melim, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 39-39
Open Access
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
Ming‐Ying Lu, Yu‐Ju Wei, Chih‐Wen Wang, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 10
Closed Access
Aerial Yam Bulbils Protect Against APAP-Induced Hepatotoxicity by Inhibiting Oxidative Stress and Mitochondrial Dysfunction Through Nrf2 Activation
Song Xiang, Dong Kwon Yang
Nutrients (2025) Vol. 17, Iss. 6, pp. 966-966
Open Access
N6-Methyladenosine Modification in the Metabolic Dysfunction-Associated Steatotic Liver Disease
Satoru Matsuda, Moeka Nakashima, Akari Fukumoto, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1158-1158
Open Access
Dual-Channel Fluorescent Probe for Simultaneously Visualizing ONOO- and Viscosity in Epilepsy, Non-Alcoholic Fatty Liver and Tumoral Ferroptosis Models
Qi Zan, Li Fan, Rui Wang, et al.
Biosensors and Bioelectronics (2025) Vol. 282, pp. 117495-117495
Closed Access
Mechanism of fibroblast growth factor 1 regulating fatty liver disorder in mule ducks
Ying-Xiu Hu, Dingding Zhang, Chao Chen, et al.
Poultry Science (2024) Vol. 103, Iss. 7, pp. 103818-103818
Open Access | Times Cited: 3
Combined transcriptomics and proteomics unveil the impact of vitamin C in modulating specific protein abundance in the mouse liver
Lucie Aumailley, Antoine Bodein, Pauline Adjibade, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 2
Amplifying hepatic L-aspartate levels suppresses CCl4-induced liver fibrosis by reversing glucocorticoid receptor β-mediated mitochondrial malfunction
Rui Su, Huiling Fu, Qian-Xue Zhang, et al.
Pharmacological Research (2024) Vol. 206, pp. 107294-107294
Open Access | Times Cited: 2
Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs
Surapriya Surendranath Prabhu, Aathira Sujathan Nair, Saiprabha Vijayakumar Nirmala
Archives of Pharmacal Research (2023) Vol. 46, Iss. 9-10, pp. 723-743
Closed Access | Times Cited: 4
Impact of mitochondrial lipid alterations on liver disease mechanisms and progression
Laura Fàbrega, José C. Fernández–Checa, Laura Conde de la Rosa, et al.
(2024), pp. 382-413
Open Access | Times Cited: 1
Sex and organ specific proteomic responses to vitamin C deficiency in the brain, heart, liver, and spleen of Gulo-/- mice
Lucie Aumailley, Michel Lebel
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0311857-e0311857
Open Access | Times Cited: 1
Probabilistic Scatter Plots for visualizing carbohydrate and lipid metabolism states in Non-Alcoholic Fatty Liver Disease
Jialin Zhou, Tengxiao Liang, Fangliang Xing, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 6, pp. 102365-102365
Open Access
The new epigenetic driver role of PPARα and mitochondria in metabolic dysfunction associated liver disease (MASLD), paving the way towards new therapeutics and diagnostic biomarkers
Claudia Theys
(2024)
Open Access
The phenomenon of metabolically associated fatty liver disease in the pathogenesis of cholelithiasis and hypertension
N. D. Molchanova, E. V. Shreiner, А. И. Хавкин, et al.
Experimental and Clinical Gastroenterology (2024), Iss. 1, pp. 83-91
Closed Access
Page 1

Scroll to top